Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System
prnewswire.com
news
2022-06-03 13:00:00

Abbott is designing a first-of-its-kind biowearable that will enable people with diabetes to continuously monitor glucose and ketones in one sensor
Device promises to redefine care for people with diabetes who are at risk for developing a life-threatening complication called diabetic ketoacidosis

ABBOTT PARK, Ill., June 3, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it's developing a new biowearable that will continuously monitor glucose and ketone levels in one sensor. The system has secured breakthrough device designation from the U.
